Dora Rau - Tourmaline Bio Senior Quality
| TRMLDelisted Stock | 47.98 0.00 0.00% |
Executive
Dora Rau is Senior Quality of Tourmaline Bio
| Phone | 646 481 9832 |
| Web | https://www.tourmalinebio.com |
Tourmaline Bio Management Efficiency
The company has return on total asset (ROA) of (0.2085) % which means that it has lost $0.2085 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2962) %, meaning that it created substantial loss on money invested by shareholders. Tourmaline Bio's management efficiency ratios could be used to measure how well Tourmaline Bio manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jeanne Gray | Relay Therapeutics | N/A | |
| Donald Lehr | Precigen | 49 | |
| Joseph MD | Syndax Pharmaceuticals | N/A | |
| Douglas Brough | Precigen | 71 | |
| Linda Arsenault | Amylyx Pharmaceuticals | N/A | |
| Ali Mohamed | Immatics NV | N/A | |
| Caryn JD | Terns Pharmaceuticals | 56 | |
| Jeffrey Stavenhagen | Dianthus Therapeutics | N/A | |
| Sharon Klahre | Syndax Pharmaceuticals | N/A | |
| Matthew Panuwat | Oric Pharmaceuticals | 48 | |
| Cedrik MD | Immatics NV | 50 | |
| Deborah MBA | Relay Therapeutics | N/A | |
| Camille MD | Amylyx Pharmaceuticals | 72 | |
| Edward Sturchio | Immatics NV | N/A | |
| Jeffrey Jasper | Terns Pharmaceuticals | N/A | |
| Kevin McManus | Syndax Pharmaceuticals | 57 | |
| Diana Chung | Terns Pharmaceuticals | N/A | |
| Daryn Lewis | Wave Life Sciences | N/A | |
| Steven Closter | Syndax Pharmaceuticals | 57 | |
| Scott Harris | Terns Pharmaceuticals | N/A | |
| Jim Watters | Relay Therapeutics | N/A | |
Management Performance
| Return On Equity | -0.3 | |||
| Return On Asset | -0.21 |
Tourmaline Bio Leadership Team
Elected by the shareholders, the Tourmaline Bio's board of directors comprises two types of representatives: Tourmaline Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Tourmaline. The board's role is to monitor Tourmaline Bio's management team and ensure that shareholders' interests are well served. Tourmaline Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Tourmaline Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Susan Jones, Chief Officer | ||
| Sandeep MD, CEO CoFounder | ||
| Kimberly Piorkowski, Culture People | ||
| Bradford JD, General Officer | ||
| Dr MBA, Chief Officer | ||
| Emil MD, Senior Research | ||
| Yung MD, Chief Officer | ||
| Gerhard PharmD, Senior Development | ||
| John MD, VP Affairs | ||
| Kristine OD, Medical Ophthalmology | ||
| Dora Rau, Senior Quality | ||
| Ryan Iarrobino, Senior Development | ||
| Famina PharmD, VP Pharmacovigilance | ||
| Don Fitch, Senior Development | ||
| Ryan CPA, Controller Finance |
Tourmaline Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Tourmaline Bio a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.3 | |||
| Return On Asset | -0.21 | |||
| Current Valuation | 993.63 M | |||
| Shares Outstanding | 25.69 M | |||
| Shares Owned By Insiders | 14.62 % | |||
| Shares Owned By Institutions | 89.12 % | |||
| Number Of Shares Shorted | 808.96 K | |||
| Price To Book | 4.75 X | |||
| EBITDA | (89.73 M) | |||
| Net Income | (73.21 M) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Tourmaline Stock
If you are still planning to invest in Tourmaline Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tourmaline Bio's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |